AI assistant
Indivior PLC — Board/Management Information 2018
Nov 16, 2018
4923_dirs_2018-11-16_17233ea4-2a23-4a53-ac64-33f31e17de3a.html
Board/Management Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6702H
Indivior PLC
16 November 2018
Indivior PLC - Director Declaration
Indivior PLC confirms that Daniel Tassé, Senior Independent Director, will be appointed Chief Executive Officer of DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq: DBVT), a clinical stage biopharmaceutical company, with effect from November 29, 2018.
There have been no other changes to the information set out in LR 9.6.13R (2) to LR 9.6.13R (6) in respect of Mr Tassé.
This announcement is made in accordance with Listing Rule 9.6.14.
Kathryn Hudson
Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
RDNFKADQPBDDFDD